£28.05
Vichy Dercos 2in1 is a dermatological shampoo and conditioner formulated for dandruff-prone scalps. This hybrid formula provides effective anti-dandruff action while simultaneously conditioning the hair fibre. It delivers instant results for visible flake removal and long-term scalp care.
- Hybrid 2in1 formula combines shampoo and conditioner in one step.
- Eliminates up to 100% of visible flakes from the first application.
- Provides nourishing conditioning benefits for hair for up to 72 hours.
- Formulated with active ingredients including Selenium disulphide and Hyaluronic acid.
- Offers sustained anti-dandruff protection for up to six weeks after use.
Experience cleaner hair and a soothed scalp with this dermatological treatment.
Read MoreDescription
xDercos Anti-Dandruff 2in1 Dermatological Conditioning Shampoo 200ml
Dercos Anti-Dandruff 2in1 Conditioning Shampoo is Vichy’s first hybrid shampoo & conditioner designed to provide instant and long-lasting results on dandruff-prone, flaky scalps.
Discover Vichy’s most loved anti-dandruff efficacy, now more conditioning & caring. Nourishes hair for up to 72H*, eliminates up to 100% of visible flakes from 1st wash** and provides anti-dandruff protection for up to 6 weeks***.
Formulated with Selenium disulphide and Hyaluronic Acid, the shampoo is designed to leave hair both flake-free and feeling more hydrated. Hair is softer, shinier and easier to detangle.
Recommended by dermatologists. Tested under dermatological control.
Suitable for all hair types. Specifically formulated for dandruff-prone scalp, flaky scalp or to refresh hair from product build up.
Did you know 1 in 2 people can suffer from dandruff? At Vichy we are committed to skin & scalp health science. Dercos treats your scalp the same way you treat your skin. We are on a mission to break dandruff taboo and promote a healthier-looking scalp and hair for all. Discover dandruff stories and scalp care advice at #mevsdandruff.
*Instrumental tests.
**Consumer test on 262 subjects after 2 weeks of regular use.
*** Clinical study on 32 subjects after 4 weeks of use and 6 weeks of remanence.
